EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY-NC 4.0

CTLA-4 +6230G>A polymorphism and its impact on CTLA-4 level and risk of hepatocellular carcinoma: A case-control study in Batak patients with chronic hepatitis B

Darmadi Darmadi, Imelda Rey, Masrul Lubis, Dharma Lindarto, Riri A Muzasti

Narra J · 2025

DOI: 10.52225/narra.v5i2.1959 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Narra J, 2025. Verfasst von Darmadi Darmadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Chronic. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic polymorphisms in cytotoxic T-lymphocyte-associated protein 4 gene (CTLA-4) vary by ethnic background, necessitating population-specific studies. The aim of this study was to assess the association between the CTLA-4 +6230G>A polymorphism, serum CTLA-4 level, and hepatocellular carcinoma (HCC) in Batak patients with chronic hepatitis B, a group with high hepatitis B virus (HBV) endemicity. A case-control study was conducted among cases (Batak patients with chronic hepatitis B and HCC) and controls (chronic hepatitis B without HCC). Genotyping of the CTLA-4 +6230G>A polymorphism was performed using the TaqMan SNP Genotyping Assay. Serum CTLA-4 level was quantified using enzyme-linked immunosorbent assay (ELISA). Patient’s demographic, clinical and laboratory data were recorded and assessed including age, sex, body mass index (BMI), smoking history, cirrhosis status, HBV DNA level, liver function markers (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)), hepatitis B e-antigen (HBeAg) status, smoking history, and alcohol consumption. This study found that G allele was significantly associated with an increased risk of HCC (OR: 2.69; 95%CI: 1.21–6.00; p=0.013). Individuals with GG/AG genotypes had a 2.89-fold higher risk of developing HCC compared to those with the AA genotype (p=0.032). Serum CTLA-4 level was significantly elevated in G allele carriers (GG: 159.9±57.1 pg/mL vs AA: 83.7±44.7 pg/mL; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CTLA-4 AntigenCarcinoma, HepatocellularLiver NeoplasmsHepatitis B, ChronicHumansCase-Control StudiesMaleFemaleMiddle AgedAdultPolymorphism, Single NucleotideGenetic Predisposition to DiseaseRisk FactorsGenotype

Stichwörter der Autor:innen

CTLA-4 geneChronic liver diseasegenetic polymorphismhepatocarcinogenesisrs3087243

Substanzen

CTLA-4 AntigenCTLA4 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.

Zitieren

APA

Darmadi, D., Rey, I., Lubis, M., Lindarto, D., & Muzasti, R. A. (2025). CTLA-4 +6230G>A polymorphism and its impact on CTLA-4 level and risk of hepatocellular carcinoma: A case-control study in Batak patients with chronic hepatitis B. Narra J. https://doi.org/10.52225/narra.v5i2.1959

Vancouver

Darmadi D, Rey I, Lubis M, Lindarto D, Muzasti RA. CTLA-4 +6230G>A polymorphism and its impact on CTLA-4 level and risk of hepatocellular carcinoma: A case-control study in Batak patients with chronic hepatitis B. Narra J. 2025. doi:10.52225/narra.v5i2.1959

BibTeX
@article{Darmadi2025,
  author = {Darmadi, Darmadi and Rey, Imelda and Lubis, Masrul and Lindarto, Dharma and Muzasti, Riri A},
  title = {CTLA-4 +6230G>A polymorphism and its impact on CTLA-4 level and risk of hepatocellular carcinoma: A case-control study in Batak patients with chronic hepatitis B},
  journal = {Narra J},
  year = {2025},
  doi = {10.52225/narra.v5i2.1959}
}
Kostenlos starten →